Findings

What do systematic reviews say?

3 questions · 3 findings · 2 reviews · Headline outcomes only

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 100%Moderate 0 · 0%High 0 · 0%

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Histological response · patients with maintenance of remission in lymphocytic colitis

Mesalazine showed no clear difference in histological response compared with mesalazine + cholestyramine (low certainty).

1 finding from 1 review

Interventions for treating lymphocytic colitis 2017 · Cochrane Headline outcomes only
RR 0.99 [0.77, 1.28]
1 study · 41 participants
Low

Histological response · Patients with collagenous colitis

Budesonide may leads to higher histological response compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating collagenous colitis 2017 · Cochrane Headline outcomes only
RR 1.97 [1.24, 3.13]
1 study · 55 participants
Low

Histological response · patients with active lymphocytic colitis

Budesonide may leads to higher histological response compared with mesalazine (low certainty).

1 finding from 1 review

Interventions for treating lymphocytic colitis 2017 · Cochrane Headline outcomes only
RR 2.44 [1.13, 5.28]
2 studies · 39 participants
Low